This is a comparative, open label, parallel group, non interventional study to further demonstrate the efficacy and tolerability of BAT04. In addition the efficacy and safety shall be compared to Hyaluronic acid (HA)-Product. The patient applies BAT04 or HA-Product according to the instructions for use six times daily in both eyes over a period of 28 days. Response to treatment is recorded at day 28.
Study Type
OBSERVATIONAL
Enrollment
64
Dr. Peter Otto
Bad Liebenwerda, Germany
Dr. Insa Beddermann
Duderstadt, Germany
Augenklinik mit Poliklinik
Erlangen, Germany
Augenklinik der LMU Klinikum der Universität Muenchen
München, Germany
Tear Break Up Time
Time frame: V1 and V2
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Augenabteilung am St. Franziskus-Hospital Münster
Münster, Germany